Eidelman Virant Capital Sells 101,500 Shares of Harte-Hanks, Inc. (HHS)

Eidelman Virant Capital cut its position in Harte-Hanks, Inc. (NYSE:HHS) by 4.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,300,100 shares of the business services provider’s stock after selling 101,500 shares during the quarter. Harte-Hanks comprises 1.5% of Eidelman Virant Capital’s holdings, making the stock its 23rd biggest position. Eidelman Virant Capital owned approximately 3.71% of Harte-Hanks worth $2,461,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of HHS. Fondren Management LP lifted its position in Harte-Hanks by 11.5% in the 2nd quarter. Fondren Management LP now owns 1,388,000 shares of the business services provider’s stock valued at $1,430,000 after purchasing an additional 143,000 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Harte-Hanks by 5.5% in the 1st quarter. Renaissance Technologies LLC now owns 1,563,100 shares of the business services provider’s stock worth $2,188,000 after purchasing an additional 81,200 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Harte-Hanks by 1.7% in the 2nd quarter. Northern Trust Corp now owns 137,956 shares of the business services provider’s stock worth $142,000 after purchasing an additional 2,278 shares during the last quarter. Hedge funds and other institutional investors own 33.87% of the company’s stock.

Several research firms have recently weighed in on HHS. Zacks Investment Research downgraded shares of Harte-Hanks from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Noble Financial reaffirmed a “hold” rating on shares of Harte-Hanks in a research report on Friday, August 18th.

TRADEMARK VIOLATION NOTICE: This piece was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/11/01/eidelman-virant-capital-sells-101500-shares-of-harte-hanks-inc-hhs.html.

Shares of Harte-Hanks, Inc. (NYSE HHS) traded down 1.92% during mid-day trading on Wednesday, hitting $1.02. 1,333 shares of the stock were exchanged. Harte-Hanks, Inc. has a 12-month low of $0.73 and a 12-month high of $1.85. The firm has a 50-day moving average price of $0.98 and a 200 day moving average price of $1.07. The company’s market capitalization is $63.26 million.

Harte-Hanks (NYSE:HHS) last announced its quarterly earnings results on Thursday, September 28th. The business services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Harte-Hanks had a negative net margin of 33.01% and a negative return on equity of 152.65%. The business had revenue of $94.72 million for the quarter, compared to analyst estimates of $94.20 million. On average, equities research analysts expect that Harte-Hanks, Inc. will post ($0.07) earnings per share for the current year.

Harte-Hanks Company Profile

Harte Hanks, Inc (Harte Hanks) is a multi-channel marketing company. The Company’s Customer Interaction business offers a range of marketing services, in media from direct mail to e-mail, including agency and digital services; database marketing solutions and business-to-business lead generation; direct mail, and contact centers.

Institutional Ownership by Quarter for Harte-Hanks (NYSE:HHS)

Receive News & Ratings for Harte-Hanks Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harte-Hanks Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply